This site is intended for healthcare professionals
News

CHMP recommends approval of Opdivo in recurrent or metastatic oesophageal squamous cell carcinoma.- BMS

Read time: 1 mins
Last updated:18th Oct 2020
Published:17th Oct 2020
Condition: Oesophageal Cancer
Type: drug
Register free for full access to medthority.com